Genomic polymorphisms of SLC29A3 associated with overall survival in advanced non-small-cell lung cancer treated with gemcitabine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genomic polymorphisms of SLC29A3 associated with overall survival in advanced non-small-cell lung cancer treated with gemcitabine

Published:2014-02-18 Issue:4 Volume:31 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Chen Xiaoxia,Zhang Ling,Ren Shengxiang,Li Xuefei,Zhou Fei,Li Wei,Gao Guanghui,He Yayi,Zhou Caicun

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-014-0865-z.pdf

Reference32 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

2. Fisher MD, D’Orazio A. Phase II and III trials: comparison of four chemotherapy regimens in advanced non small-cell lung cancer (ECOG 1594). Clin Lung Cancer. 2000;2:21–2.

3. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 2006;355:2542–50.

4. Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361:947–57.

5. Rosell R, Manegold C, Moran T, Garrido P, Blanco R, et al. Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer. Clin Lung Cancer. 2008;9(Suppl 2):S76–82.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kombo knife combined with sorafenib in liver cancer treatment: Efficacy and safety under immune function influence;World Journal of Gastrointestinal Oncology;2024-07-15

2. SLC29A3 as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma;Asian Journal of Surgery;2024-04

3. Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers;Diseases;2024-03-21

4. Equilibrative nucleotide transporter ENT3 (SLC29A3): A unique transporter for inherited disorders and cancers;Experimental Cell Research;2024-01

5. MiR‐1224‐5p acts as a tumor suppressor via inhibiting the malignancy of rectal cancer through targeting SLC29A3;IUBMB Life;2020-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3